VISHEE(SH:688580) Xin Lang Cai Jing·2025-12-18 05:46Group 1 - The core viewpoint of the news is that Weisi Medical has seen a stock price increase of 5.05%, reaching 46.98 CNY per share, with a total market capitalization of 4.499 billion CNY [1] - Weisi Medical, established on January 10, 2001, focuses on the research, production, and sales of rehabilitation medical devices, particularly in areas such as pelvic floor and postpartum rehabilitation, neurological rehabilitation, and mental rehabilitation [1] - The company's revenue composition includes: magnetic stimulation products (39.44%), consumables and accessories (19.42%), electrophysiological products (19.18%), laser radiofrequency products (10.26%), electrical stimulation products (8.42%), and others (3.28%) [1] Group 2 - From the perspective of fund holdings, Weisi Medical is a top ten holding of Huayin Fund Management, specifically in the Beixin Ruifeng Health Life Theme Flexible Allocation Fund (001056), which reduced its holdings by 15,000 shares to 75,000 shares, representing 4.13% of the fund's net value [2] - The Beixin Ruifeng Health Life Theme Flexible Allocation Fund (001056) was established on March 27, 2015, with a latest scale of 90.1431 million CNY, achieving a year-to-date return of 18.8% and a one-year return of 11.21% [2] - The fund manager, Pang Wenjie, has been in position for 5 years and 202 days, with the fund's total asset scale at 18.4 million CNY, achieving a best return of 44.46% and a worst return of -46.46% during his tenure [3]